Trials / Unknown
UnknownNCT02784015
Response Based Treatment for Children With Unresectable Localized Soft Tissue Sarcoma
Response-based Treatment for Children With Unresectable Localized Soft Tissue Sarcomas
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 41 (estimated)
- Sponsor
- Samsung Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the treatment outcome of unresectable soft tissue sarcoma using response based treatment
Detailed description
Response after initial chemotherapy is one of the important prognostic factor in many cancers. In this study, treatment will be tailored according to the treatment responses which are assessed by tumor volume reduction, necrosis rate or residual fludeoxyglucose (FDG) uptake in positron emission tomography (PET) scan.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Cisplatin | |
| DRUG | Etoposide | |
| DRUG | Doxorubicin | |
| DRUG | Cyclophosphamide | |
| DRUG | Ifosfamide | |
| DRUG | Carboplatin | |
| RADIATION | Radiotherapy | |
| DRUG | Thiotepa | |
| DRUG | Melphalan |
Timeline
- Start date
- 2016-05-01
- Primary completion
- 2020-05-01
- Completion
- 2023-05-01
- First posted
- 2016-05-26
- Last updated
- 2018-09-18
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02784015. Inclusion in this directory is not an endorsement.